Dáil Éireann Debate, Wednesday - 9 November 2022
108. Deputy Kieran O'Donnell asked the Minister for Health the status of the Freestyle Libre2 application for reimbursement on the HSE's long-term illness scheme through the community-funded aids and appliances. [55668/22]
Amharc ar fhreagraThe Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medical devices in the community drug schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013.
The HSE’s Primary Care Reimbursement Service (PCRS) has responsibility for the administration of and reimbursement under the community drug schemes. The FreeStyle Libre 2 Continuous Glucose Monitoring (CGM) devices for those with Type I Diabetes are funded under a separate funding mechanism locally. Hence, applications for the reimbursement of such devices do not go through the PCRS.
There is a national tender arrangement in place for Aids and Appliances, such as CGM devices, under the community funded schemes and the hospital must apply for funding for those patients where a CGM device is warranted. In order for the FreeStyle Libre 2 CGM device to be added to the CGM devices available under the community funded schemes national tender arrangements, the marketing authorisation holder for the FreeStyle Libre 2 CGM device will need to apply through the national framework application process.
